Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activation

American Journal of Pathology

Volumn 182, Issue 3, 2013, Pages 992-1004

  Trimmer, Casey ^a   Bonuccelli, Gloria ^a   Katiyar, Sanjay ^a   Sotgia, Federica ^a   Pestell, Richard G ^a   Lisanti, Michael P ^a   Capozza, Franco ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CYCLIN D1; CYTOKERATIN 18; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; LYMPH NODE METASTASIS; MODULATION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN CARCINOMA; WESTERN BLOTTING;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CAVEOLIN 1; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; GENE KNOCKDOWN TECHNIQUES; HUMANS; KERATIN-18; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SERUM; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-1;

EID: 84874545903     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.11.008     Document Type: Article

References (85)

1. D.T. Gray, V.J. Suman, W.P. Su, R.P. Clay, W.S. Harmsen, and R.K. Roenigk Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992 Arch Dermatol 133 1997 735 740
2. D.L. Miller, and M.A. Weinstock Nonmelanoma skin cancer in the United States: incidence J Am Acad Dermatol 30 1994 774 778
3. H.W. Rogers, M.A. Weinstock, A.R. Harris, M.R. Hinckley, S.R. Feldman, A.B. Fleischer, and B.M. Coldiron Incidence estimate of nonmelanoma skin cancer in the United States, 2006 Arch Dermatol 146 2011 283 287
4. D. Czarnecki, M. Staples, A. Mar, G. Giles, and C. Meehan Metastases from squamous cell carcinoma of the skin in southern Australia Dermatology 189 1994 52 54
5. M.G. Joseph, W.P. Zulueta, and P.J. Kennedy Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome Aust N Z J Surg 62 1992 697 701
6. M. Alam, and D. Ratner Cutaneous squamous-cell carcinoma N Engl J Med 344 2001 975 983
7. B.S. Cherpelis, C. Marcusen, and P.G. Lang Prognostic factors for metastasis in squamous cell carcinoma of the skin Dermatol Surg 28 2002 268 273
8. B. Razani, and M.P. Lisanti Caveolins and caveolae: molecular and functional relationships Exp Cell Res 271 2001 36 44
9. A.W. Cohen, R. Hnasko, W. Schubert, and M.P. Lisanti Role of caveolae and caveolins in health and disease Physiol Rev 84 2004 1341 1379
10. M.P. Lisanti, P.E. Scherer, Z. Tang, and M. Sargiacomo Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis Trends Cell Biol 4 1994 231 235
11. S. Li, K.S. Song, and M.P. Lisanti Expression and characterization of recombinant caveolin: purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes J Biol Chem 271 1996 568 573
12. B. Razani, J.A. Engelman, X.B. Wang, W. Schubert, X.L. Zhang, C.B. Marks, F. Macaluso, R.G. Russell, M. Li, R.G. Pestell, D. Di Vizio, H. Hou Jr., B. Kneitz, G. Lagaud, G.J. Christ, W. Edelmann, and M.P. Lisanti Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities J Biol Chem 276 2001 38121 38138
13. T. Roelandt, C. Giddelo, C. Heughebaert, G. Denecker, M. Hupe, D. Crumrine, A. Kusuma, M. Haftek, D. Roseeuw, W. Declercq, K.R. Feingold, P.M. Elias, and J.P. Hachem The "caveolae brake hypothesis" and the epidermal barrier J Invest Dermatol 129 2009 927 936
14. F. Capozza, T.M. Williams, W. Schubert, S. McClain, B. Bouzahzah, F. Sotgia, and M.P. Lisanti Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation Am J Pathol 162 2003 2029 2039
15. L. Campbell, and M. Gumbleton Aberrant caveolin-1 expression in psoriasis: a signalling hypothesis IUBMB Life 50 2000 361 364
16. L. Campbell, P. Laidler, R.E. Watson, B. Kirby, C.E. Griffiths, and M. Gumbleton Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis Br J Dermatol 147 2002 701 709
17. S. Langlois, K.N. Cowan, Q. Shao, B.J. Cowan, and D.W. Laird The tumor-suppressive function of Connexin43 in keratinocytes is mediated in part via interaction with caveolin-1 Cancer Res 70 2011 4222 4232
18. S.H. Yuspa, P. Hawley-Nelson, B. Koehler, and J.R. Stanley A survey of transformation markers in differentiating epidermal cell lines in culture Cancer Res 40 1980 4694 4703
19. J.G. Rheinwald, and M.A. Beckett Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas Cancer Res 41 1981 1657 1663
20. M. Schon, and J.G. Rheinwald A limited role for retinoic acid and retinoic acid receptors RAR alpha and RAR beta in regulating keratin 19 expression and keratinization in oral and epidermal keratinocytes J Invest Dermatol 107 1996 428 438
21. F. Capozza, A.W. Cohen, M.W. Cheung, F. Sotgia, W. Schubert, M. Battista, H. Lee, P.G. Frank, and M.P. Lisanti Muscle-specific interaction of caveolin isoforms: differential complex formation between caveolins in fibroblastic vs. muscle cells Am J Physiol Cell Physiol 288 2005 C677 C691
22. C. Trimmer, F. Sotgia, D. Whitaker-Menezes, R.M. Balliet, G. Eaton, U.E. Martinez-Outschoorn, S. Pavlides, A. Howell, R.V. Iozzo, R.G. Pestell, P.E. Scherer, F. Capozza, and M.P. Lisanti Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts Cancer Biol Ther 11 2011 383 394
23. F. Capozza, T.P. Combs, A.W. Cohen, Y.R. Cho, S.Y. Park, W. Schubert, T.M. Williams, D.L. Brasaemle, L.A. Jelicks, P.E. Scherer, J.K. Kim, and M.P. Lisanti Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle Am J Physiol Cell Physiol 288 2005 C1317 C1331
24. C. Trimmer, D. Whitaker-Menezes, G. Bonuccelli, J.N. Milliman, K.M. Daumer, A.E. Aplin, R.G. Pestell, F. Sotgia, M.P. Lisanti, and F. Capozza CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway Cancer Res 70 2011 7489 7499
25. P.B. Gupta, C. Kuperwasser, J.P. Brunet, S. Ramaswamy, W.L. Kuo, J.W. Gray, S.P. Naber, and R.A. Weinberg The melanocyte differentiation program predisposes to metastasis after neoplastic transformation Nat Genet 37 2005 1047 1054
26. M.W. Pfaffl, G.W. Horgan, and L. Dempfle Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR Nucleic Acids Res 30 2002 e36
27. P.E. Scherer, R.Y. Lewis, D. Volonte, J.A. Engelman, F. Galbiati, J. Couet, D.S. Kohtz, E. van Donselaar, P. Peters, and M.P. Lisanti Cell-type and tissue-specific expression of caveolin-2: caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo J Biol Chem 272 1997 29337 29346
28. V.R. Yanofsky, S.E. Mercer, and R.G. Phelps Histopathological variants of cutaneous squamous cell carcinoma: a review J Skin Cancer 2011 2011 210813
29. A.C. Markey, E.B. Lane, L.J. Churchill, D.M. MacDonald, and I.M. Leigh Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia J Invest Dermatol 97 1991 763 770
30. F. Larcher, C. Bauluz, M. Diaz-Guerra, M. Quintanilla, C.J. Conti, C. Ballestin, and J.L. Jorcano Aberrant expression of the simple epithelial type II keratin 8 by mouse skin carcinomas but not papillomas Mol Carcinog 6 1992 112 121
31. C. Caulin, C. Bauluz, A. Gandarillas, A. Cano, and M. Quintanilla Changes in keratin expression during malignant progression of transformed mouse epidermal keratinocytes Exp Cell Res 204 1993 11 21
32. R.G. Oshima, H. Baribault, and C. Caulin Oncogenic regulation and function of keratins 8 and 18 Cancer Metastasis Rev 15 1996 445 471
33. Y. Yamashiro, K. Takei, M. Umikawa, T. Asato, M. Oshiro, Y. Uechi, T. Ishikawa, K. Taira, H. Uezato, and K. Kariya Ectopic coexpression of keratin 8 and 18 promotes invasion of transformed keratinocytes and is induced in patients with cutaneous squamous cell carcinoma Biochem Biophys Res Commun 399 2011 365 372
34. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
35. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
36. A. John, and G. Tuszynski The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis Pathol Oncol Res 7 2001 14 23
37. D.E. Kleiner, and W.G. Stetler-Stevenson Matrix metalloproteinases and metastasis Cancer Chemother Pharmacol 43 Suppl 1999 S42 S51
38. R. Pankov, A. Umezawa, R. Maki, C.J. Der, C.A. Hauser, and R.G. Oshima Oncogene activation of human keratin 18 transcription via the Ras signal transduction pathway Proc Natl Acad Sci U S A 91 1994 873 877
39. K. Rhodes, and R.G. Oshima A regulatory element of the human keratin 18 gene with AP-1-dependent promoter activity J Biol Chem 273 1998 26534 26542
40. R.G. Oshima, L. Abrams, and D. Kulesh Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells Genes Dev 4 1990 835 848
41. R. Pankov, N. Neznanov, A. Umezawa, and R.G. Oshima AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells Mol Cell Biol 14 1994 7744 7757
42. H. Alam, S.T. Kundu, S.N. Dalal, and M.M. Vaidya Loss of keratins 8 and 18 leads to alterations in alpha6beta4-integrin-mediated signalling and decreased neoplastic progression in an oral-tumour-derived cell line J Cell Sci 124 2011 2096 2106
43. Y. Messai, M.Z. Noman, A. Derouiche, N. Kourda, I. Akalay, M. Hasmim, I. Stasik, S. Ben Jilani, M. Chebil, A. Caignard, B. Azzarone, A. Gati, A. Ben Ammar Elgaaied, and S. Chouaib Cytokeratin 18 expression pattern correlates with renal cell carcinoma progression: relationship with Snail Int J Oncol 36 2011 1145 1154
44. Y.W. Chu, E.A. Seftor, L.H. Romer, and M.J. Hendrix Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility Am J Pathol 148 1996 63 69
45. F. Bordeleau, L. Galarneau, S. Gilbert, A. Loranger, and N. Marceau Keratin 8/18 modulation of protein kinase C-mediated integrin-dependent adhesion and migration of liver epithelial cells Mol Biol Cell 21 2011 1698 1713
46. G. Dong, E. Loukinova, Z. Chen, L. Gangi, T.I. Chanturita, E.T. Liu, and C. Van Waes Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway Cancer Res 61 2001 4797 4808
47. A. Loercher, T.L. Lee, J.L. Ricker, A. Howard, J. Geoghegen, Z. Chen, J.B. Sunwoo, R. Sitcheran, E.Y. Chuang, J.B. Mitchell, A.S. Baldwin Jr., and C. Van Waes Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma Cancer Res 64 2004 6511 6523
48. Z. Chen, C.W. Smith, D. Kiel, and C. Van Waes Metastatic variants derived following in vivo tumor progression of an in vitro transformed squamous cell carcinoma line acquire a differential growth advantage requiring tumor-host interaction Clin Exp Metastasis 15 1997 527 537
49. C.W. Smith, Z. Chen, G. Dong, E. Loukinova, M.Y. Pegram, L. Nicholas-Figueroa, and C. Van Waes The host environment promotes the development of primary and metastatic squamous cell carcinomas that constitutively express proinflammatory cytokines IL-1alpha, IL-6, GM-CSF, and KC Clin Exp Metastasis 16 1998 655 664
50. G. Dong, Z. Chen, T. Kato, and C. Van Waes The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma Cancer Res 59 1999 3495 3504
51. E. Loukinova, Z. Chen, C. Van Waes, and G. Dong Expression of proangiogenic chemokine Gro 1 in low and high metastatic variants of Pam murine squamous cell carcinoma is differentially regulated by IL-1 alpha, EGF and TGF-beta1 through NF-kappaB dependent and independent mechanisms Int J Cancer 94 2001 637 644
52. K. Ridd, S. Dhir, A.G. Smith, and T.W. Gant Defective TPA signalling compromises HaCat cells as a human in vitro skin carcinogenesis model Toxicol In Vitro 24 2010 910 915
53. Y. Miyazaki, H. Yokozeki, S. Awad, K. Igawa, K. Minatohara, T. Satoh, I. Katayama, and K. Nishioka Glucocorticoids augment the chemically induced production and gene expression of interleukin-1alpha through NF-kappaB and AP-1 activation in murine epidermal cells J Invest Dermatol 115 2000 746 752
54. Z. Chen, S.I. Rosten, E.M. Lord, and A.A. Gaspari Murine Pam 212 cutaneous squamous cell carcinoma is nonimmunogenic in normal syngeneic hosts and resistant to immune effector mechanisms Reg Immunol 5 1993 285 292
55. M. Cargnello, and P.P. Roux Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases Microbiol Mol Biol Rev 75 2011 50 83
56. S. Meloche, and J. Pouyssegur The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition Oncogene 26 2007 3227 3239
57. E.F. Wagner, and A.R. Nebreda Signal integration by JNK and p38 MAPK pathways in cancer development Nat Rev Cancer 9 2009 537 549
58. E.K. Kim, and E.J. Choi Pathological roles of MAPK signaling pathways in human diseases Biochim Biophys Acta 1802 2011 396 405
59. T. Boutros, E. Chevet, and P. Metrakos Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer Pharmacol Rev 60 2008 261 310
60. A. Plotnikov, E. Zehorai, S. Procaccia, and R. Seger The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation Biochim Biophys Acta 1813 2011 1619 1633
61. A.G. Turjanski, J.P. Vaque, and J.S. Gutkind MAP kinases and the control of nuclear events Oncogene 26 2007 3240 3253
62. A.J. Whitmarsh Regulation of gene transcription by mitogen-activated protein kinase signaling pathways Biochim Biophys Acta 1773 2007 1285 1298
63. J.A. Engelman, C. Chu, A. Lin, H. Jo, T. Ikezu, T. Okamoto, D.S. Kohtz, and M.P. Lisanti Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo: a role for the caveolin-scaffolding domain FEBS Lett 428 1998 205 211
64. F. Galbiati, D. Volonte, J.A. Engelman, G. Watanabe, R. Burk, R.G. Pestell, and M.P. Lisanti Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade EMBO J 17 1998 6633 6648
65. T.M. Williams, H. Lee, M.W. Cheung, A.W. Cohen, B. Razani, P. Iyengar, P.E. Scherer, R.G. Pestell, and M.P. Lisanti Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia J Biol Chem 279 2004 24745 24756
66. J.A. Engelman, C.C. Wykoff, S. Yasuhara, K.S. Song, T. Okamoto, and M.P. Lisanti Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth J Biol Chem 272 1997 16374 16381
67. M. Blumenberg Transcriptional Regulation of Keratin Gene Expression Paramio J, 2006 Landes Bioscience Georgetown, TX 93 109
68. P. Lopez-Bergami, C. Huang, J.S. Goydos, D. Yip, M. Bar-Eli, M. Herlyn, K.S. Smalley, A. Mahale, A. Eroshkin, S. Aaronson, and Z. Ronai Rewired ERK-JNK signaling pathways in melanoma Cancer Cell 11 2007 447 460
69. G.N. Sando, H. Zhu, J.M. Weis, J.T. Richman, P.W. Wertz, and K.C. Madison Caveolin expression and localization in human keratinocytes suggest a role in lamellar granule biogenesis J Invest Dermatol 120 2003 531 541
70. J.A. Engelman, X.L. Zhang, F. Galbiati, and M.P. Lisanti Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3): Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31) FEBS Lett 429 1998 330 336
71. J.A. Engelman, X.L. Zhang, and M.P. Lisanti Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers FEBS Lett 436 1998 403 410
72. J.C. Zenklusen, J.C. Thompson, A.J. Klein-Szanto, and C.J. Conti Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene Cancer Res 55 1995 1347 1350
73. J.A. Engelman, X.L. Zhang, and M.P. Lisanti Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1): methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines FEBS Lett 448 1999 221 230
74. N. Sunaga, K. Miyajima, M. Suzuki, M. Sato, M.A. White, R.D. Ramirez, J.W. Shay, A.F. Gazdar, and J.D. Minna Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer Cancer Res 64 2004 4277 4285
75. L. Menendez, D. Walker, L.V. Matyunina, E.B. Dickerson, N.J. Bowen, N. Polavarapu, B.B. Benigno, and J.F. McDonald Identification of candidate methylation-responsive genes in ovarian cancer Mol Cancer 6 2007 10
76. M.W. Coolen, C. Stirzaker, J.Z. Song, A.L. Statham, Z. Kassir, C.S. Moreno, A.N. Young, V. Varma, T.P. Speed, M. Cowley, P. Lacaze, W. Kaplan, M.D. Robinson, and S.J. Clark Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity Nat Cell Biol 12 2010 235 246
77. K. Hayashi, S. Matsuda, K. Machida, T. Yamamoto, Y. Fukuda, Y. Nimura, T. Hayakawa, and M. Hamaguchi Invasion activating caveolin-1 mutation in human scirrhous breast cancers Cancer Res 61 2001 2361 2364
78. J.A. Engelman, X.L. Zhang, B. Razani, R.G. Pestell, and M.P. Lisanti p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression: activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity J Biol Chem 274 1999 32333 32341
79. A.J. Koleske, D. Baltimore, and M.P. Lisanti Reduction of caveolin and caveolae in oncogenically transformed cells Proc Natl Acad Sci U S A 92 1995 1381 1385
80. B. Razani, Y. Altschuler, L. Zhu, R.G. Pestell, K.E. Mostov, and M.P. Lisanti Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner: replacement of caveolin-1 expression suppresses HPV-mediated cell transformation Biochemistry 39 2000 13916 13924
81. S. Bolshakov, C.M. Walker, S.S. Strom, M.S. Selvan, G.L. Clayman, A. El-Naggar, S.M. Lippman, M.L. Kripke, and H.N. Ananthaswamy p53 Mutations in human aggressive and nonaggressive basal and squamous cell carcinomas Clin Cancer Res 9 2003 228 234
82. D.E. Brash Roles of the transcription factor p53 in keratinocyte carcinomas Br J Dermatol 154 Suppl 1 2006 8 10
83. W.E. Pierceall, L.H. Goldberg, M.A. Tainsky, T. Mukhopadhyay, and H.N. Ananthaswamy Ras gene mutation and amplification in human nonmelanoma skin cancers Mol Carcinog 4 1991 196 202
84. T.A. Khavari, and J. Rinn Ras/Erk MAPK signaling in epidermal homeostasis and neoplasia Cell Cycle 6 2007 2928 2931
85. G.L. Clayman, J.J. Lee, F.C. Holsinger, X. Zhou, M. Duvic, A.K. El-Naggar, V.G. Prieto, E. Altamirano, S.L. Tucker, S.S. Strom, M.L. Kripke, and S.M. Lippman Mortality risk from squamous cell skin cancer J Clin Oncol 23 2005 759 765